0001140361-15-045394.txt : 20151222
0001140361-15-045394.hdr.sgml : 20151222
20151222175904
ACCESSION NUMBER: 0001140361-15-045394
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150304
FILED AS OF DATE: 20151222
DATE AS OF CHANGE: 20151222
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arbutus Biopharma Corp
CENTRAL INDEX KEY: 0001447028
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980597776
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
BUSINESS PHONE: 604-419-3200
MAIL ADDRESS:
STREET 1: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
FORMER COMPANY:
FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS Corp
DATE OF NAME CHANGE: 20110607
FORMER COMPANY:
FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS CORP
DATE OF NAME CHANGE: 20081003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kowalski Mark
CENTRAL INDEX KEY: 0001628357
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34949
FILM NUMBER: 151303834
MAIL ADDRESS:
STREET 1: C/O TEKMIRA PHARMACEUTICALS CORP,
STREET 2: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
4
1
doc1.xml
FORM 4
X0306
4
2015-03-04
1
0001447028
Arbutus Biopharma Corp
ABUS
0001628357
Kowalski Mark
C/O ARBUTUS BIOPHARMA CORP.
SUITE 100, 8900 GLENLYON PARKWAY
BURNABY
A1
V5J 5J8
BRITISH COLUMBIA, CANADA
0
1
0
0
Sr VP & Chief Medical Officer
/s/ Mark Kowalski
2015-12-22